Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Amplia Therapeutics Ltd. (INNMF) had Consolidated Net Income/Loss of -5.10M for the most recently reported fiscal year, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
-5.10M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.10M |
|
|
Consolidated Net Income/Loss |
-5.10M |
-- |
|
-- |
|
-- |
|
510.00M |
|
510.00M |
|
-0.01 |
|
-0.01 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|